Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial

BACKGROUND AND AIMS: Multiple studies have demonstrated the efficacy of aminosalicylates in maintaining remission in ulcerative colitis (UC). A newer formulation of mesalamine can be administered once daily. We aimed to examine the efficacy and tolerability of pH-dependent mesalamine for long-term m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kane, Sunanda, Holderman, William, Jacques, Peter, Miodek, Todd
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770408/
https://www.ncbi.nlm.nih.gov/pubmed/19920971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770408/
https://www.ncbi.nlm.nih.gov/pubmed/19920971

Ejemplares similares